Plasmacytoid dendritic cell leukemia: A rapidly evolving disease presenting with skin lesions sensitive to radiotherapy plus hyperthermia

Oncologist

Volumn 14, Issue 12, 2009, Pages 1205-1208

  Tecchio, Cristina ^a   Colato, Chiara ^a   Bonifacio, Massimiliano ^a   Krampera, Mauro ^a   Maluta, Sergio ^b   Pizzolo, Giovanni ^a   Girolomoni, Giampiero ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Plasmacytoid dendritic cell leukemia; Radiotherapy plus hyperthermia; Therapy

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; HYDROXYUREA; METHOTREXATE; PREDNISONE; VINCRISTINE;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW BIOPSY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CASE REPORT; DISEASE COURSE; DRUG MEGADOSE; GENERAL CONDITION DETERIORATION; HUMAN; HUMAN TISSUE; HYPERTHERMIC THERAPY; LEUKEMIA; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PLASMACYTOID DENDRITIC CELL LEUKEMIA; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RELAPSE; SKIN BIOPSY; SKIN DEFECT; SKIN NODULE; THERAPY EFFECT;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DENDRITIC CELLS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; HYPERTHERMIA, INDUCED; LEUKEMIA; MALE; MIDDLE AGED; SKIN NEOPLASMS;

EID: 75449089941     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2009-0184     Document Type: Article

References (15)

1. Garnache-Ottou F, Feuillard J, Ferrand C et al. Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia. Br J Haematol 2009;145:624-636.
2. Willemze R, Jaffe ES, Burg G et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005;105:3768-3785.
3. Chaperot L, Bendriss N, Manches O et al. Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood 2001;97:3210-3217.
4. Herling M, Jones D. CD4+/CD56+ hematodermic tumor: The features of an evolving entity and its relationship to dendritic cells. Am J Clin Pathol 2007;127:687-700.
5. Petrella T, Bagot M, Willemze R et al. Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): A review. Am J Clin Pathol 2005;123:662-675.
6. Ascani S, Massone C, Ferrara G et al. CD4-negative variant of CD4+/CD56+ hematodermic neoplasm: Description of three cases. J Cutan Pathol 2008;35:911-915.
7. Feuillard J, Jacob MC, Valensi F et al. Clinical and biologic features of CD4+CD56+ malignancies. Blood 2002;99:1556-1563.
8. Marafioti T, Paterson JC, Ballabio E et al. Novel markers of normal and neoplastic human plasmacytoid dendritic cells. Blood 2008;111:3778-3792.
9. Jardin F, Callanan M, Penther D et al. Recurrent genomic aberrations combined with deletions of various tumour suppressor genes may deregulate the G1/S transition in CD4+CD56+ haematodermic neoplasms and contribute to the aggressiveness of the disease. Leukemia 2009;23:698-707.
10. Reimer P, Rüdiger T, Kraemer D et al. What is CD4+CD56+ malignancy and how should it be treated? Bone Marrow Transplant 2003;32:637-646.
11. Assaf C, Gellrich S, Whittaker S et al. CD56-positive haematological neoplasms of the skin: A multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer. J Clin Pathol 2007;60:981-989.
12. Fontaine J, Thomas L, Balme B et al. Haematodermic CD4+CD56+ neoplasm: Complete remission after methotrexate-asparaginase treatment. Clin Exp Dermatol 2009;34:e43-e45.
13. Petersen IA, Kapp DS. Local hyperthermia and radiation therapy in the retreatment of superficially located recurrences in Hodgkin's disease. Int J Radiat Oncol Biol Phys 1990;18:603-611.
14. Donato V, Zurlo A, Nappa M et al. Multicentre experience with combined hyperthermia and radiation therapy in the treatment of superficially located non-Hodgkin's lymphomas. J Exp Clin Cancer Res 1997;16:87-90.
15. Moyer HR, Delman KA. The role of hyperthermia in optimizing tumor response to regional therapy. Int J Hyperthermia 2008;24:251-261.